NAmur MEdicine & Drug Innovation Center

Research output

Research output per year 1987 2012 2013 2014 2015 2016 2017 2018 2019 2023 2024

• 7376 Citations
• 45 h-index
• 312 Article
• 187 Poster
• 74 Conference contribution
• 24 Review article
• 55 More
  • 16 Literature review
  • 8 Letter
  • 6 Chapter
  • 5 Other contribution
  • 3 Meeting abstract
  • 2 Chapter (peer-reviewed)
  • 2 Paper
  • 2 Editorial
  • 2 Short survey
  • 2 Patent
  • 1 Commissioned report
  • 1 Catalog chapter contribution
  • 1 Abstract
  • 1 Other
  • 1 Comment/debate
  • 1 Special issue
  • 1 Master's Thesis

Research output per year

Research output per year

Search results

• 2003

  Recent developments in 5-lipoxygenase inhibitors

  Julémont, F., Dogné, J. M., Laeckmann, D., Pirotte, B. & de Leval, X., 1 Jan 2003, In: Expert Opinion on Therapeutic Patents. 13, 1, p. 1-13 13 p.

  Research output: Contribution to journal › Review article › peer-review

  • Lipoxygenase Inhibitor 100%
  • Lipoxygenases 100%
  • Leukotriene 66%
  • Lipoxygenase 66%
  • Arachidonate 5 Lipoxygenase 66%
• 2010

  La communication pédagogique en cours magistral de chimie: Peut-on en améliorer l'efficacité ?

  Houart, M., Warzée, N., Wouters, J., Reniers, F. & Romainville, M., 2010, In: Actualité Chimique. 341

  Research output: Contribution to journal › Review article › peer-review

• 2013

  Rivaroxaban (Xarelto®): Guide de la pratique officinale

  Translated title of the contribution: Rivaroxaban: Xarelto® - Recommendations for pharmacistsDouxfils, J., Michel, S., Beauloye, C., Goethals, M., Hainaut, P., Heidbuchel, H., Hermans, C., Ickx, B., Jochmans, K., Mottes, S., Mullier, F., Peeters, A., Scavée, C., Sinnaeve, P., Sprynger, M., Thijs, V., Vandenbroeck, C., Vandermeulen, E., Verhamme, P. & Dogné, J. M., 1 Mar 2013, In: Journal de Pharmacie de Belgique. 1, p. 28-36 9 p.

  Research output: Contribution to journal › Review article › peer-review

  Open Access

  File

  • Pharmacist 100%
  • Rivaroxaban 100%
  • Anticoagulant Agent 40%
  • Biological Monitoring 20%
  • Vitamin K Antagonist 20%
  976 Downloads (Pure)
• 2014

  Les mirages des nouveaux anticoagulants oraux.

  Translated title of the contribution: The mirages of the new oral anticoagulantsLarock, A. S., Mullier, F., Laloux, P., Douxfils, J., Dogné, J. M. & Spinewine, A., 2014, In: Journal de Pharmacie de Belgique. 1, p. 38-41 4 p.

  Research output: Contribution to journal › Review article › peer-review

  Open Access

  File
  101 Downloads (Pure)

• Management of Non-Vitamin K Antagonist Oral Anticoagulants in the Perioperative Setting

  Dincq, A-S., Lessire, S., Douxfils, J., Dogné, J-M., Gourdin, M. & Mullier, F., 2014, In: BioMed research international. 2014, 385014.

  Research output: Contribution to journal › Review article › peer-review

  File

  • Anticoagulant Agent 100%
  • Antivitamin K 100%
  • Drug 25%
  • Absence 25%
  • Rivaroxaban 25%
  71 Downloads (Pure)

• Measurement of non-VKA oral anticoagulants versus classic ones: The appropriate use of hemostasis assays

  Douxfils, J., Tamigniau, A., Chatelain, B., Goffinet, C., Dogné, J. M. & Mullier, F., 4 Nov 2014, In: Thrombosis journal. 12, 24, p. 1-18 18 p.

  Research output: Contribution to journal › Review article › peer-review

  Open Access

  File

  • Anticoagulant Agent 100%
  • Antivitamin K 100%
  • Thromboembolism 50%
  • Heparin 50%
  • Low Molecular Weight Heparin 33%
  90 Downloads (Pure)

• Pourquoi, quand et comment doser les nouveaux anticoagulants oraux?

  Translated title of the contribution: Why, when and how monitor new oral anticoagulants?Tamigniau, A., Douxfils, J., Nicolas, J. B., Devalet, B., Larock, A. S., Spinewine, A., Dincq, A. S., Lessire, S., Gourdin, M., Watelet, J. B., Mathieux, V., Chatelain, C., Dogné, J. M., Chatelain, B. & Mullier, F., 5 Feb 2014, In: Revue médicale suisse. 10, 416, p. 326-333 8 p.

  Research output: Contribution to journal › Review article › peer-review

  File

  • Anticoagulant Agent 100%
  • Direct Oral Anticoagulant 100%
  • Thromboembolism 40%
  • Drug 20%
  • Toxic Injury 20%
  125 Downloads (Pure)

• Preventive strategies against bleeding due to nonvitamin K antagonist oral anticoagulants

  Lessire, S., Dincq, A. S., Douxfils, J., Devalet, B., Nicolas, J. B., Spinewine, A., Larock, A. S., Dogné, J. M., Gourdin, M. & Mullier, F., 2014, In: BioMed research international. 2014, 616405.

  Research output: Contribution to journal › Review article › peer-review

  Open Access

  File

  • Gastrointestinal Hemorrhage 100%
  • Brain Hemorrhage 100%
  72 Downloads (Pure)

• Suivi biologique des patients sous nouveaux anticoagulants oraux: qui, quand, comment ?

  Mullier, F., Douxfils, J., Tamigniau, A., Dogne, J-M., Horellou, M-H., Flaujac, C., Chatelain, B., Samama, M. M. & Gouin-Thibault, I., 2014, In: Feuillets de Biologie. 55, 319, p. 5-14

  Research output: Contribution to journal › Review article › peer-review

• 2015

  Anticoagulants directs oraux: Actualités pour les biologistes

  Translated title of the contribution: Non-VKA oral anticoagulants: An update for the clinical biologistsMullier, F., Douxfils, J., Tamigniau, A., Dogné, J. M., Horellou, M. H., Flaujac, C., Chatelain, B., Goffinet, C., Samama, M. M. & Gouin-Thibault, I., 1 May 2015, In: Annales de biologie clinique. 73, 3, p. 333-344 12 p.

  Research output: Contribution to journal › Review article › peer-review

  • Anticoagulant Agent 100%
  • Drug 50%
  • Toxic Injury 50%
  • Ensure 50%
  • Thromboembolism 50%
• 2016

  Facing coagulation disorders after acute trauma

  Mullier, F., Lessire, S., De Schoutheete, J. C., Chatelain, B., Deneys, V., Mathieux, V., Hachimi Idrissi, S., Dogne, J. M., Watelet, J. B., Gourdin, M. & Dincq, A. S., 1 Jan 2016, In: B-ENT. 12, 1, p. 67-85 19 p.

  Research output: Contribution to journal › Review article › peer-review

  Open Access

  File

  • Patient 100%
  • Coagulopathy 100%
  • Bleeding 60%
  • Mortality 40%
  • Injury 40%
  38 Downloads (Pure)

• Heparin monitoring - clinical outcome and practical approach

  Despas, N., Larock, A-S., Jacqmin, H., Douxfils, J., Chatelain, B., Chatelain, M. & Mullier, F., 2016, In: Annales de biologie clinique. 74, 6, p. 637-652 16 p.

  Research output: Contribution to journal › Review article › peer-review

  • Anticoagulant Agent 100%
  • Heparin 100%
  • Low Molecular Weight Heparin 100%
  • Monitoring 100%
  • Antithrombotic 57%

• New insights into the synthesis and biological activity of the pamamycin macrodiolides

  Hanquet, G., Salom-Roig, X. & Lanners, S., 1 Feb 2016, In: Chimia. 70, 1-2, p. 20-28 9 p.

  Research output: Contribution to journal › Review article › peer-review

  • Synthesis (Chemical) 100%
  • Biosynthesis 100%
  • Biological Property 100%
  • Bioactivity 100%
  • Total Synthesis 100%
• 2017

  Clinical pearls: Laboratory assessments of direct oral anticoagulants (DOACS)

  Gosselin, R., Douxfils, J. & Adcock, D., 2017, In: Hamostaseologie. 37, 4, p. 295-301 7 p.

  Research output: Contribution to journal › Review article › peer-review

  Open Access

  • Direct Oral Anticoagulant 100%
  • Thrombin 20%
  • Blood Clotting Factor 10a 20%
  • Venous Thromboembolism 20%
  • Atrial Fibrillation 20%

• Non-vitamin-Koral anticoagulants and laboratory testing: Now and in the future: Views from a workshop at the European Medicines Agency (EMA)

  Salmonson, T., Dogne, J. M., Janssen, H., Burgos, J. G. & Blake, P., 1 Jan 2017, In: European Heart Journal - Cardiovascular Pharmacotherapy. 3, 1, p. 42-47 6 p.

  Research output: Contribution to journal › Review article › peer-review

  Open Access

  • Vitamin 100%
  • Vitamin K 100%
  • Laboratory Test 100%
  • Anticoagulant Agent 100%
  • Vitamin K Group 66%
• 2018

  Laboratory Testing In Patients Treated With Direct Oral Anticoagulants: A Practical Guide For Clinicians

  Douxfils, J., Ageno, W., Samama, C-M., Lessire, S., Ten Cate, H., Verhamme, P., Dogné, J-M. & Mullier, F., 1 Feb 2018, In: Journal of thrombosis and haemostasis : JTH. 16, 2, p. 209-219 11 p.

  Research output: Contribution to journal › Review article › peer-review

  Open Access

  File

  • Direct Oral Anticoagulant 100%
  • Anticoagulant Agent 20%
  • Reagent 10%
  • Rivaroxaban 10%
  • Apixaban 10%
  130 Downloads (Pure)

• Therapeutic applications of prostaglandins and thromboxane A ₂ inhibitors in abdominal aortic aneurysms

  Courtois, A., Makrygiannis, G., Cheramy-Bien, J. P., Purnelle, A., Pirotte, B., Dogné, J. M., Hanson, J., Defraigne, J. O., Drion, P. & Sakalihasan, N., 1 Jan 2018, In: Current Drug Targets. 19, 11, p. 1247-1255 9 p.

  Research output: Contribution to journal › Review article › peer-review

  • Prostaglandin 100%
  • Thromboxane 100%
  • Abdominal Aortic Aneurysm 100%
  • Prostanoid 37%
  • Acetylsalicylic Acid 37%
• 2019

  An update on laboratory assessment for direct oral anticoagulants (DOACs)

  Gosselin, R. C., Adcock, D. M. & Douxfils, J., 1 May 2019, In: International Journal of Laboratory Hematology. 41, S1, p. 33-39 7 p.

  Research output: Contribution to journal › Review article › peer-review

  Open Access

  File

  • Direct Oral Anticoagulant 100%
  • Drug 14%
  • Anticoagulant Agent 14%
  • Thrombin Inhibitor 14%
  • Rivaroxaban 14%
  52 Downloads (Pure)
• 2020

  Factor XII/XIIa inhibitors: Their discovery, development, and potential indications

  DAVOINE, C., BOUCKAERT, C., Fillet, M. & POCHET, L., 1 Dec 2020, In: European Journal of Medicinal Chemistry. 208, 112753.

  Research output: Contribution to journal › Review article › peer-review

  Open Access

  File

  • Development 100%
  • Factor XII 100%
  • Blood Clotting Factor 12 100%
  • Protein 28%
  • Antibody 28%
  60 Downloads (Pure)
• 2022

  Liquid Biopsy in Glioblastoma

  Ronvaux, L., RIVA, M., Coosemans, A., Herzog, M., ROMMELAERE, G., Donis, N., D'HONDT, L. & Douxfils, J., 13 Jul 2022, In: Cancers (Basel). 14, 14, 3394.

  Research output: Contribution to journal › Review article › peer-review

  Open Access

  File

  • Circulating microRNA 100%
  • Brain Tumor 100%
  • Circulating Tumor DNA 100%
  18 Downloads (Pure)
• 2023

  Clinical Chemistry and Laboratory Medicine celebrates 60 years: narrative review devoted to the contribution of the journal to the diagnosis of SARS-CoV-2

  Favresse, J., Douxfils, J., Henry, B., Lippi, G. & Plebani, M., 1 Apr 2023, In: Clinical Chemistry and Laboratory Medicine. 61, 5, p. 811-821 11 p.

  Research output: Contribution to journal › Review article › peer-review

  Open Access

  • Severe Acute Respiratory Syndrome Coronavirus 2 100%
  • Diagnosis 100%
  • COVID-19 100%
  • Laboratory Medicine 100%
  • Laboratory 20%

• D-dimer testing: A narrative review

  Wauthier, L., Favresse, J., Hardy, M., Douxfils, J., Le Gal, G., Roy, P. M., van Es, N., Ay, C., Ten Cate, H., Lecompte, T., Lippi, G. & Mullier, F., Jan 2023, In: Advances in clinical chemistry. 114, p. 151-223 73 p.

  Research output: Contribution to journal › Review article › peer-review

  • Species 100%
  • Degradation 100%
  • Screening 100%
  • Pregnancy 100%
  • Age 100%

• Periodic DFT Computation of Rotational Barriers for Linear Molecules in Zeolites: Validation via Zero-Point Energies and Isotopic Heat Difference Values of Adsorbed H2/D2

  Rybakov, A., Trubnikov, D. N., Vercauteren, D. & Larin, A., 15 Jan 2023, In: Materials Chemistry and Physics . 294, 12 p., 126929.

  Research output: Contribution to journal › Review article › peer-review

  • Molecule 100%
  • Zeolite 100%
  • Density Functional Theory 100%
  • Zero Point Energy 100%
  • Heat 100%

• Safety Monitoring of COVID-19 Vaccines: Perspective from the European Medicines Agency

  Durand, J., Dogné, J. M., Cohet, C., Browne, K., Gordillo-Marañón, M., Piccolo, L., Zaccaria, C. & Genov, G., Jun 2023, In: Clinical Pharmacology and Therapeutics. 113, 6, p. 1223-1234 12 p., 10.1002/cpt.2828.

  Research output: Contribution to journal › Review article › peer-review

  Open Access

  File

  • COVID-19 100%
  • Vaccine 100%
  • Interpersonal Communication 28%
  • Syndrome 28%
  • Thrombocytopenia 28%